<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="ribavirin/PMC4542094/results/search/disease/results.xml">
  <result pre="chemotherapy is likely to be associated with the development of" exact="cancer" post="stem cell-like phenotypes. This chemical stress can force the"/>
  <result pre="to induce a wide HCT8 subpopulation of cells (HCT8RETO) with" exact="cancer" post="stem cell features (CSCs) in a very short time."/>
  <result pre="(CRC). Nevertheless, this drug is associated with the induction of" exact="cancer" post="stem cell characteristics in several tumors as previously described."/>
  <result pre="expressed in colon carcinomas, probably due to the presence of" exact="cancer" post="stem cells. The expression of different HERVs and a"/>
  <result pre="have an impact on tumor biology and/or proliferation of chemorefractory" exact="cancer" post="cells in vitro. Enhanced cytotoxic effect of antiviral compounds"/>
  <result pre="indicating unspecific cytotoxic effects of antiviral compounds rather than additional" exact="suppression" post="of HERV-protein expression. Fig. 6 Cytotoxic effect of antiviral"/>
  <result pre="expression of various HERV proteins is not only detectable in" exact="colon cancer" post="cells, but might also have therapeutic implications for CRC"/>
  <result pre="of various HERV proteins is not only detectable in colon" exact="cancer" post="cells, but might also have therapeutic implications for CRC"/>
  <result pre="[22, 23]. Recently, we described a method to induce multi-resistant" exact="cancer" post="cells that express several CSC tissue-related markers as well"/>
  <result pre="has been also linked to stemness in both normal and" exact="cancer" post="cells [36]. Colon adenocarcinoma paraffin sections showed significant expression"/>
  <result pre="proteins to promote cell-cell fusion and generation of multinucleated giant" exact="cancer" post="cells could represent an alternative membrane-mediated defense mechanism [12,"/>
  <result pre="anti-HERV-K-specific monoclonal antibodies inhibited tumor growth and induced apoptosis of" exact="breast cancer" post="cells [39]. These data served as a rationale to"/>
  <result pre="monoclonal antibodies inhibited tumor growth and induced apoptosis of breast" exact="cancer" post="cells [39]. These data served as a rationale to"/>
  <result pre="downregulation of HERV proteins in a panel of HERV-expressing chemoresistant" exact="cancer" post="cell lines. Among these compounds, the structurally unrelated amantadine,"/>
  <result pre="PPAPs were recently described as selective agents in highly resistant" exact="neuroblastoma" post="entities [40–43], exerting a pleiotropic effect that involves the"/>
  <result pre="expression of various HERV proteins might have therapeutic implications in" exact="colorectal cancer." post="Therefore, the introduction of antiviral compounds to the current"/>
  <result pre="al.Atypical cell populations associated with acquired resistance to cytostatics and" exact="cancer" post="stem cell features: the role of mitochondria in nuclear"/>
  <result pre="in nuclear encapsulationDNA Cell Biol201433117497410.1089/dna.2014.237525126674 2.MezhirJJAdvaniSJSmithKDDargaTEPoonAPSchmidtHet al.Ionizing radiation activates late" exact="herpes simplex" post="virus 1 promoters via the p38 pathway in tumors"/>
  <result pre="of human endogenous retroviral long terminal repeat sequences in human" exact="cancer" post="(Review)Int J Mol Med20133247556223900638 6.PacesJHuangYTPačesVRídlJChangCMNew insight into transcription of"/>
  <result pre="non-coding spliced transcripts from human endogenous retrovirus HERV-H elements in" exact="colon cancer." post="PLoS One. 7(1):e29950. 23.LeeSHKangYJJoJOOckMSBaekKWEoJet al.Elevation of human ERV3-1 env"/>
  <result pre="of eIF4E with ribavirin cooperates with common chemotherapies in primary" exact="acute myeloid leukemia" post="specimensLeukemia2011257119720010.1038/leu.2011.5721455212 26.BordenKLCuljkovic-KraljacicBRibavirin as an anti-cancer therapy: acute myeloid leukemia"/>
  <result pre="eIF4E with ribavirin cooperates with common chemotherapies in primary acute" exact="myeloid leukemia" post="specimensLeukemia2011257119720010.1038/leu.2011.5721455212 26.BordenKLCuljkovic-KraljacicBRibavirin as an anti-cancer therapy: acute myeloid leukemia"/>
  <result pre="with ribavirin cooperates with common chemotherapies in primary acute myeloid" exact="leukemia" post="specimensLeukemia2011257119720010.1038/leu.2011.5721455212 26.BordenKLCuljkovic-KraljacicBRibavirin as an anti-cancer therapy: acute myeloid leukemia"/>
  <result pre="primary acute myeloid leukemia specimensLeukemia2011257119720010.1038/leu.2011.5721455212 26.BordenKLCuljkovic-KraljacicBRibavirin as an anti-cancer therapy:" exact="acute myeloid leukemia" post="and beyond?Leuk Lymphoma2010511018051510.3109/10428194.2010.49650620629523 27.BordenKLTargeting the oncogene eIF4E in cancer:"/>
  <result pre="acute myeloid leukemia specimensLeukemia2011257119720010.1038/leu.2011.5721455212 26.BordenKLCuljkovic-KraljacicBRibavirin as an anti-cancer therapy: acute" exact="myeloid leukemia" post="and beyond?Leuk Lymphoma2010511018051510.3109/10428194.2010.49650620629523 27.BordenKLTargeting the oncogene eIF4E in cancer:"/>
  <result pre="myeloid leukemia specimensLeukemia2011257119720010.1038/leu.2011.5721455212 26.BordenKLCuljkovic-KraljacicBRibavirin as an anti-cancer therapy: acute myeloid" exact="leukemia" post="and beyond?Leuk Lymphoma2010511018051510.3109/10428194.2010.49650620629523 27.BordenKLTargeting the oncogene eIF4E in cancer:"/>
  <result pre="Invest Med2011346E31522129918 28.AssoulineSCuljkovicBCocolakisERousseauCBesluNAmriAet al.Molecular targeting of the oncogene eIF4E in" exact="acute myeloid leukemia" post="(AML): a proof-of-principle clinical trial with ribavirinBlood200911422576010.1182/blood-2009-02-20515319433856 29.AssoulineSCuljkovic-KraljacicBBergeronJCaplanSCocolakisELambertCA phase"/>
  <result pre="Med2011346E31522129918 28.AssoulineSCuljkovicBCocolakisERousseauCBesluNAmriAet al.Molecular targeting of the oncogene eIF4E in acute" exact="myeloid leukemia" post="(AML): a proof-of-principle clinical trial with ribavirinBlood200911422576010.1182/blood-2009-02-20515319433856 29.AssoulineSCuljkovic-KraljacicBBergeronJCaplanSCocolakisELambertCA phase"/>
  <result pre="28.AssoulineSCuljkovicBCocolakisERousseauCBesluNAmriAet al.Molecular targeting of the oncogene eIF4E in acute myeloid" exact="leukemia" post="(AML): a proof-of-principle clinical trial with ribavirinBlood200911422576010.1182/blood-2009-02-20515319433856 29.AssoulineSCuljkovic-KraljacicBBergeronJCaplanSCocolakisELambertCA phase"/>
  <result pre="and low-dose cytarabine for the treatment of relapsed and refractory" exact="acute myeloid leukemia" post="with elevated eIF4EHaematologica20151001e7910.3324/haematol.2014.11124525425688 30.Díaz-CarballoDMalakSBardenheuerWFreistuehlerMReuschHPCytotoxic activity of nemorosone in neuroblastoma"/>
  <result pre="low-dose cytarabine for the treatment of relapsed and refractory acute" exact="myeloid leukemia" post="with elevated eIF4EHaematologica20151001e7910.3324/haematol.2014.11124525425688 30.Díaz-CarballoDMalakSBardenheuerWFreistuehlerMReuschHPCytotoxic activity of nemorosone in neuroblastoma"/>
  <result pre="cytarabine for the treatment of relapsed and refractory acute myeloid" exact="leukemia" post="with elevated eIF4EHaematologica20151001e7910.3324/haematol.2014.11124525425688 30.Díaz-CarballoDMalakSBardenheuerWFreistuehlerMReuschHPCytotoxic activity of nemorosone in neuroblastoma"/>
  <result pre="myeloid leukemia with elevated eIF4EHaematologica20151001e7910.3324/haematol.2014.11124525425688 30.Díaz-CarballoDMalakSBardenheuerWFreistuehlerMReuschHPCytotoxic activity of nemorosone in" exact="neuroblastoma" post="cellsJ Cell Mol Med2008126B259860810.1111/j.1582-4934.2008.00232.x18194446 31.TallaridaRJAn overview of drug combination"/>
  <result pre="with isobologramsJ Pharmacol Exp Ther200631911710.1124/jpet.106.10411716670349 32.Díaz-CarballoDAcikelliAHGustmannSBardenheuerWStrumbergDAcquired resistance to cytostatics triggers" exact="cancer" post="stem-cell-like phenotype in different tumor entitiesJ Stem Cells Regen"/>
  <result pre="cancerOncogene2003221015283510.1038/sj.onc.120624112629516 35.GolanMHiziAResauJHYaal-HahoshenNReichmanHKeydarIet al.Human endogenous retrovirus (HERV-K) reverse transcriptase as a" exact="breast cancer" post="prognostic markerNeoplasia20081065213310.1593/neo.0798618516289 36.OhnukiMTanabeKSutouKTeramotoISawamuraYNaritaMet al.Dynamic regulation of human endogenous retroviruses"/>
  <result pre="35.GolanMHiziAResauJHYaal-HahoshenNReichmanHKeydarIet al.Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast" exact="cancer" post="prognostic markerNeoplasia20081065213310.1593/neo.0798618516289 36.OhnukiMTanabeKSutouKTeramotoISawamuraYNaritaMet al.Dynamic regulation of human endogenous retroviruses"/>
  <result pre="43.Díaz-CarballoDAcikelliAHBardenheuerWGustmannSMalakSStollRet al.Identification of compounds that selectively target highly chemotherapy refractory" exact="neuroblastoma" post="cancer stem cellsInt J Clin Pharmacol Ther201452978780110.5414/CP20215424902844 44.YuHLiuTZhaoZChenYZengJLiuSet al.Mutations"/>
  <result pre="al.Identification of compounds that selectively target highly chemotherapy refractory neuroblastoma" exact="cancer" post="stem cellsInt J Clin Pharmacol Ther201452978780110.5414/CP20215424902844 44.YuHLiuTZhaoZChenYZengJLiuSet al.Mutations in"/>
 </snippets>
</snippetsTree>
